Koninklijke Philips PHG
NYSE PHG
$27.42 -0.08 (-0.29%)
At close: Aug 21, 2026 · 4:00 PM EDT

Koninklijke Philips (PHG) Gains from Sales and Divestitures (2010 - 2013)

Koninklijke Philips (PHG) posted quarterly Gains from Sales and Divestitures of $9.1 million for Q2 2013, up 117.78% year-over-year from $4.2 million in Q2 2012, and up 186.53% quarter-over-quarter from -$10.6 million in Q1 2013.

Koninklijke Philips (PHG) Gains from Sales and Divestitures (2010 - 2013) Analysis & Trends

Koninklijke Philips' Gains from Sales and Divestitures history runs 4 years deep, the most recent figure standing at $9.1 million for Q2 2013.

  • In Q2 2013, Gains from Sales and Divestitures rose 117.78% year-over-year to $9.1 million; the TTM figure through Jun 2013 stood at $68.8 million (down 89.92% YoY), while the FY2012 annual figure was $39.9 million, down 94.26% from the prior year.
  • Gains from Sales and Divestitures for Q2 2013 stood at $9.1 million, up from -$10.6 million in the prior quarter.
  • The five-year high for Gains from Sales and Divestitures was $366.6 million in Q4 2011, with the low at -$51.4 million in Q2 2012.
  • The 4-year median for Gains from Sales and Divestitures is $23.6 million (2012), against an average of $90.9 million.
  • The sharpest annual moves came in 2011 and 2013: Gains from Sales and Divestitures jumped 1674.77% in 2011, then slumped 144.75% in 2013.
  • Koninklijke Philips' Gains from Sales and Divestitures stood at $51.6 million in 2010, then soared by 610.38% to $366.6 million in 2011, then plunged by 69.93% to $110.2 million in 2012, then slumped by 91.71% to $9.1 million in 2013.
  • Business Quant data shows PHG's Gains from Sales and Divestitures at $9.1 million in Q2 2013, -$10.6 million in Q1 2013, and $110.2 million in Q4 2012.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 202.72 Bn 197.12 Bn 7.27 Bn
2 Stryker 126.42 Bn 122.94 Bn 4.50 Bn
3 Medtronic 119.75 Bn 110.53 Bn 6.41 Bn
4 Boston Scientific 74.13 Bn 73.60 Bn 3.85 Bn
5 Edwards Lifesciences 51.78 Bn 47.53 Bn 1.35 Bn
6 Dexcom 35.29 Bn 33.34 Bn 830.00 Mn
7 GE HealthCare Technologies 33.95 Bn 31.85 Bn 2.18 Bn
8 Koninklijke Philips 26.22 Bn 22.90 Bn 4.55 Bn
9 Steris 23.21 Bn 22.73 Bn 684.20 Mn
10 Zimmer Biomet Holdings 19.42 Bn 19.01 Bn 1.54 Bn

Historic Data

Download Data
DateValue
Jun 30, 2013 9.14 Mn
Jun 30, 2013 9.14 Mn
Mar 31, 2013 -10.56 Mn
Mar 31, 2013 -10.56 Mn
Dec 31, 2012 110.24 Mn
Dec 31, 2012 110.24 Mn
Sep 30, 2012 -40.02 Mn
Sep 30, 2012 -40.02 Mn
Jun 30, 2012 -51.40 Mn
Jun 30, 2012 -51.40 Mn
Mar 31, 2012 23.60 Mn
Mar 31, 2012 23.60 Mn
Dec 31, 2011 366.58 Mn
Dec 31, 2011 366.58 Mn
Sep 30, 2011 343.76 Mn
Sep 30, 2011 343.76 Mn
Jun 30, 2011 271.87 Mn
Jun 30, 2011 271.87 Mn
Mar 31, 2011 125.81 Mn
Mar 31, 2011 125.81 Mn